Tolerx, Inc.
Private Company
Follow
View Corporate Tree
Create Alert
Basic Info
Headquarter
Massachusetts, United States
Founded Year
2000
Employees
50-100
Stock Symbol
NASDAQ: TLRX
Social Media
http://www.tolerx.com
Tolerx, Inc. is a company that provides Autoimmune disease, Otelixizumab, Type 1 diabetes and more. Tolerx, Inc. is headquartered in United States Massachusetts. Tolerx, Inc. was founded in 2000. Tolerx, Inc. has a total of 68 patents
Related Topics
Login to view all basic info
Innovation Word Cloud
A quick overview of tech portfolio with the top keywords and phrases extracted from patents of Tolerx, Inc.
Download
High Related Markets
Mentioned companies in the market reports of major market categories and sectors by Tolerx, Inc.
Sign up to view the full dataFree Trial Now
Innovation Matrix
visualizing technology portfolio of hot application areas and blank areas for Tolerx, Inc.
Time Range:
Overall
Application Domain L2
Tech Topic L2
Download
Subsidiary Lists
Subsidiaries with patent applications for Tolerx, Inc.
Sign up to view the full dataFree Trial Now
Tolerx, Inc. Frequently Asked Questions
What technical fields has Tolerx, Inc. researched?
What is Tolerx, Inc.'s total number of patents?
How many employees does Tolerx, Inc. have globally?
Tolerx, Inc. has 51 employees worldwide.
Show all question
Related Companies
CBA Pharma, Inc.Kentucky, United States
Image Analysis Ltd.England, United Kingdom
Standigm Co. Ltd.Seoul-t'ukpyolsi, South Korea
NovelMed Therapeutics, Inc.Ohio, United States
Cancer Care OntarioOntario, Canada
EDP Biotech Corp.Tennessee, United States
Betagenon Sweden ABVasterbottens Lan, Sweden
BioLamina ABStockholms Lan, Sweden
Nutra Pharma Corp.Florida, United States
Login to view all
Hot Companies in Industries
Popular
Autoimmune disease
Type 1 diabetes
Viral disease
Antibody
Cancer
ShopifyRedditTik tokAppleSquarespaceSoundcloudMediumParallelsZoomGoogleGodaddyMicrosoftForbesEtsyHuawei TechnologiesYandexAmazonEvent briteDribbbleHatenaWalmartWPengineUberSplunkServiceNowTwilioHubSpotMuleSoftBloombergCargill
Amgen, Inc.Vertex Pharmaceuticals, Inc.Seagen Inc.Elan Pharmaceuticals, LLCCorixa Corp.Rigel Pharmaceuticals, Inc.ChemoCentryx, Inc.Biovitrum ABSynta Pharmaceuticals Corp.4SC AGRhizen Pharmaceuticals AGCytomX Therapeutics, Inc.MediGene AGUnited Biomedical, Inc.Elan Corp. PlcRedx Pharma PlcMagenta Therapeutics, Inc.LFB Biotechnologies SASUIDEC Pharmaceuticals Corp.Boston Biomedical, Inc.Micromet AGKaryopharm Therapeutics, Inc.Phadia ABHangzhou Zhongmeihuadong Pharmaceutical Co., Ltd.Emergent Product Development SeattleAxikin Pharmaceuticals, Inc.Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd.Rubius Therapeutics, Inc.medac Gesellschaft für klinische Spezialprparate mbHAlembic Pharmaceuticals Ltd.
Amylin Pharmaceuticals, Inc.The Walter & Eliza Hall Institute of Medical ResearchWilson Wolf Manufacturing Corp.Creative Peptides Sweden ABBenaroya Research Institute at Virginia MasonAkston Biosciences Corp.Vactech OyProvention Bio, Inc.Semma Therapeutics, Inc.Topas Therapeutics GmbHREGiMMUNE Corp.AiMedics Pty Ltd.Dreamed Diabetes Ltd.Actinobac Biomed, Inc.DiaKine Therapeutics, Inc.JDRF International
Gilead Pharmasset LLCJanssen Global Services LLCRoche Palo Alto LLCBERLIN-CHEMIE AGHealth Protection AgencyPanacos Pharmaceuticals, Inc.Kineta, Inc. (Washington)Serenex, Inc.Avixgen, Inc.Ambrilia Biopharma, Inc.Intracel Corp.IncellDx, Inc.Complix NVThe Aaron Diamond AIDS Research CenterViroLogik GmbHSenex Biotechnology, Inc.Atara Biotherapeutics, Inc.Profectus BioSciences, Inc.SMS Pharmaceuticals Ltd.Virostatics SrlKinoPharma, Inc.LeukoSite, Inc.Aptimmune Biologics, Inc.Lymphact - Lymphocyte Activation Technologies SAVEROVACCiNES GmbHGenitrix LLCHarrisvaccines, Inc.Zymetx, Inc.Prestizia SASUNutra Pharma Corp.
Amgen, Inc.Regeneron Pharmaceuticals, Inc.Chugai Pharmaceutical Co., Ltd.Incyte Corp.ZymoGenetics, Inc.Immatics Biotechnologies GmbHKissei Pharmaceutical Co., Ltd.ImmunoGen, Inc.Seagen Inc.OncoTherapy Science, Inc.Immunomedics, Inc.Medarex, Inc.Ablynx NVModernaTX, Inc.Roche Glycart AGMacroGenics, Inc.Xencor, Inc.CuraGen Corp.CSL Ltd.MorphoSys AGThe Henry M. Jackson FoundationSigma-Aldrich Co. Ltd.Agensys, Inc.Sorrento Therapeutics, Inc.Bioverativ Therapeutics, Inc.Octapharma AGInnate Pharma SAImClone LLCRadiometer A/SRinat Neuroscience Corp.
F. Hoffmann-La Roche Ltd.Nippon Kayaku Co., Ltd.Wisconsin Alumni Research FoundationClarient, Inc.SyntheX, Inc.Immatics Biotechnologies GmbHExelixis, Inc.Corixa Corp.Rigel Pharmaceuticals, Inc.Alexion Pharmaceuticals, Inc.Medarex, Inc.Pharmacyclics LLCElekta ABMedivir ABChemoCentryx, Inc.MacroGenics, Inc.National Health Research InstitutesJuno Therapeutics, Inc.Biovitrum ABKanazawa UniversityEpigenomics AGH. Lee Moffitt Cancer Center & Research Institute, Inc.Synta Pharmaceuticals Corp.Xinxiang Medical UniversitySorrento Therapeutics, Inc.Curis, Inc.Tottori UniversityNanjing Medical UniversityAgios Pharmaceuticals, Inc.Inovio Pharmaceuticals, Inc.
View more
People also Viewed
Arts Et Metiers ParistechZhengzhou Customs Technical Center patentsHenan Lushui Qingshan Environmental Protection Technology competitorsShanghai Sinko Air Conditioning Equipment patentsMoodagent competitorsSichuan Jinshan Pharmaceutical company profileChongqing Hechuan District Chuanzhou Peach ChipsChongqing Yuanhuang Machinery Manufacturing competitorsCloud Finger Intelligent TechnologyProud competitorsXinjiang Huixiang Laser Technology company profileswizzzCut patentsSilicon GraphicsXi'an Xuhao Environmental Protection TechnologyZhejiang Qixing Industrial company profileZHUHAITIONAL RESOURCES&JINGJIE IMAGING PRODUCTS company profileWeather Modification Office of Xinjiang Uygur Autonomous Region patentsPersonas y Tecnología competitorsLong Tai Copper competitorsACCO Brands competitorsCover-Pools competitorsQing Tao Automation Equipment competitorsInBev company profileAlkaliDx patentsBeijing Jiashi Lianbo Medicine Technology company profilePanasonic Ecology Systems Guangdong competitorsHenan Dacheng General Aviation Technology company profileSuzhou Qianchen Automation Technology company profileHKC patentsSMS
Page generation time: Feb 25 2023